Clinical Trial Update: Safety and Feasibility Study of the CELLSPAN Esophageal Implant (CEI) in Patients Requiring Short Segment Esophageal Replacement [Phase 1]

View source ↗

Summary

Phase 1 safety and feasibility study evaluating the CELLSPAN Esophageal Implant (CEI) for short-segment esophageal replacement is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Disease

Drugs mentioned

• CELLSPAN Esophageal Implant (CEI)

Snippet

Sponsor: Harvard Apparatus Regenerative Technology, Inc. | Conditions: Esophageal Diseases | Phase 1 | Status: RECRUITING